STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

Rhea-AI Summary

Agilent Technologies (NYSE: A) has acquired Avida Biomed, a life sciences firm specializing in target enrichment workflows for cancer research. This acquisition enhances Agilent's SureSelect portfolio and positions the company for expansion in clinical research and diagnostics. Avida's innovative technology allows for simultaneous genomic and DNA methylation profiling from a single sample, improving efficiency. This strategic move will enable Agilent to better support oncology researchers and advance precision medicine applications globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference on January 5, 2023, at 2:05 p.m. ET, and the J.P. Morgan Healthcare Conference on January 10, 2023, at 9:00 a.m. PT. Both events will be webcasted live, accessible via Agilent's Investor Relations website. Agilent is recognized as a leader in the life sciences and diagnostics fields, generating $6.85 billion in revenue in fiscal 2022 and employing 18,000 people globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
conferences
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has received FDA approval for the Resolution ctDx FIRST, a liquid biopsy companion diagnostic to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from KRAZATI (adagrasib). This marks the first FDA-approved liquid biopsy NGS assay as a CDx for KRAZATI. The assay provides broad genomic profiling on 109 genes, facilitating treatment decisions for approximately 14% of NSCLC patients with KRAS mutations and 32% with EGFR mutations. The minimally invasive approach allows for faster diagnostics, benefiting patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. has opened a new Customer Experience Center (CEC) in Lexington, Massachusetts, aimed at enhancing customer education in genomics and diagnostics. This facility will act as a hub for hands-on training, product demonstrations, and workflow solutions, catering to a growing base of pathologists, clinicians, and researchers. The CEC's strategic location ensures accessibility for a high concentration of Agilent's customers. The company generated $6.85 billion in revenue in fiscal 2022, underlining its significant market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has become the first 'Angel' level sponsor of My Green Lab, enhancing its support for laboratory sustainability. This partnership allows Agilent to access strategic insights to aid customers in achieving sustainability goals. The company also sponsors the Green Lab Certification program, which promotes best practices in lab sustainability. Agilent's labs in Germany, the UK, and Santa Clara have achieved the highest certification level. This initiative aligns with Agilent's commitment to environmental and social governance (ESG) standards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.68%
Tags
none
Rhea-AI Summary

Agilent Technologies (NYSE: A) has announced the deployment of its Insight200M liquid explosive detection system at London Heathrow airport, enhancing airport security and efficiency. This advanced system, compliant with ECAC standards, improves passenger throughput with a low false alarm rate. The technology aligns with Heathrow's shift to computed tomography X-ray screening, aiming to simplify security processes while maintaining safety. The Insight200M system is a continuation of a partnership dating back to 2013, with minimal operational disruption during deployment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) announced a 7% increase in its quarterly dividend to 22.5 cents per share, payable on January 25, 2023, to shareholders on record as of January 3, 2023. This decision reflects the company's strong performance, having generated $6.32 billion in revenue in fiscal 2021. Future dividends will be decided by Agilent's board of directors, subject to risks and uncertainties outlined in their SEC filings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.82%
Tags
dividends
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) will present at the 5th Annual Evercore ISI HealthCONx conference on November 30 at 10:50 a.m. PST. CEO Mike McMullen and CFO Bob McMahon will lead the presentation. A live webcast and audio archive will be available on Agilent's Investor Relations website. Agilent is a global leader in life sciences and diagnostics, generating $6.32 billion in revenue in 2021, with a workforce of 17,000 employees worldwide. For more information, visit www.agilent.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $134.49 as of November 25, 2024.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 38.5B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.

Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

38.48B
286.42M
0.27%
91.2%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA